Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 28, 2017
Pharmaron, a fully integrated contract research organization offering R&D services to the life sciences industry, has signed a definitive agreement under which Pharmaron will acquire a majority stake in Shin Nippon Biomedical Laboratories Clinical ...
read more
Tuesday, February 28, 2017
TrialScope, a provider of clinical trial transparency and compliance solutions, today announced the launch of the Trial Results Summaries Portal, a publicly accessible website where clinical trial sponsors can inform and educate trial participants ...
read more
Tuesday, February 28, 2017
The Cryoport Biotech Regenerative Therapy Activity Index (the "CoBRA IndexSM") quantifies the activity in the development and clinical trials of regenerative therapies in the United States, and acts as a means by which investors, the media and ...
read more
CRB announced that Ryan Schroeder, senior associate and Midwest region leader, will transition to president and oversee worldwide operations and the performance of all business units. Jeff Biskup, a founding partner and the company's current ...
read more
INC Research Holdings, a global Phase I to IV contract research organization, has announced the appointment of William E. Klitgaard and Linda S. Harty to the Company’s Board of Directors effective immediately.
read more
Pharmaceutical Product Development has secured the fifth renewal of its long-standing contract with the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The ...
read more
Alcami, a provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, and Bruker AXS, a supplier of analytical X-ray solutions, has announced the delivery of Bruker's D8 DISCOVER HTS™ high-throughput...
read more
Mayne Pharma has entered into a long-term exclusive license and supply agreement with Mithra Pharmaceuticals SA (Mithra) for Myring®, an intravaginal hormonal contraceptive delivery device.
read more
INC Research Holdings, a global Phase I to IV contract research organization (CRO), and Medidata a provider of cloud-based solutions and data analytics for clinical research, announced an expanded technology partnership, helping life sciences ...
read more
Lyophilization Services of New England, Inc. (LSNE) has announced the successful completion of two FDA inspections of their aseptic manufacturing facilities. These inspections were conducted in January and February of 2017.
read more
Glenmark Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) cleared the Company's Investigational New Drug (IND) application to begin a Phase 2 study of GSP 304 (tiotropium bromide) for administration by nebulization for ...
read more
Novasep, a supplier of services and technologies for the life sciences industry, has announced the appointment of Xavier de Saint Guilhem as Chief Financial Officer.
nitially trained at ENSCP, MIT (Massachusetts Institute of Technology) and INSEAD, ...
read more
Bioversys AG and Aptuit have announced the start of a joint collaboration aimed at the identification and validation of novel targets and molecules for Gram-negative bacteria. Aptuit and BioVersys hope that innovative approaches can address ...
read more
Ampersand Capital Partners and 1315 Capital, has completed the acquisition of Genoptix, Inc. from Novartis. The financial terms of the transaction are not being disclosed.
read more
ACD/Labs, an informatics company that develops and commercializes solutions in support of chemical and pharmaceutical R&D, will introduce LUMINATA™, an informatics system that enables organizations to establish effective impurity control strategies. ...
read more